Key facts
- Future Fields’s last known valuation is $2.1M (Jun 2020).
- It has raised $22.4M.
- Notable investors include Y Combinator, Pioneer Fund, Climate Capital, Bossa Invest, BDC Capital — 29 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for Future Fields
- ·The full record, as it builds
Funding rounds
No funding rounds for Future Fields are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Future Fields
Developer of a biotechnology platform designed to produce high-value proteins through sustainable biomanufacturing using fruit flies. The company offers a range of recombinant proteins, including custom and difficult-to-express proteins, enabling researchers and biopharmaceutical developers access to scalable, sustainable, and cost-effective protein production that accelerates scientific progress.
- Sector
- Healthcare
- HQ
- Edmonton, Canada
- Founded
- 2018
- Employees
- 42
- Website
- futurefields.io/
- Ownership
- Privately Held (backing)
Future Fields doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Future Fields shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Future Fields in its N-PORT filings yet. We sweep new filings monthly.